(VIANEWS) – NORSKE SKOG (NSKOG.OL), SPBK1 NORD-NORGE (NONG.OL), AZERION (AZRN.AS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NORSKE SKOG (NSKOG.OL)
32.1% sales growth and 8.63% return on equity
Norske Skog ASA engages in the production and sale of publication and packaging paper products in Norway, rest of Europe, North America, Australasia, Asia, and Africa. It operates in Publication paper Europe, Publication paper Australasia, and Packaging paper segments. The company offers newsprint paper products comprising standard newsprint and other papers; magazine papers, including super calendared and lightweight coated papers; and recycled containerboards. Its products are primarily used in newspapers and magazines, periodicals, catalogues, brochures, advertising materials, inserts/flyers, supplements, free-sheets, directories, direct mail, and books. Norske Skog ASA was founded in 1962 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NORSKE SKOG has a trailing twelve months EPS of kr5.72.
PE Ratio
NORSKE SKOG has a trailing twelve months price to earnings ratio of 6.64. Meaning, the purchaser of the share is investing kr6.64 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.63%.
More news about NORSKE SKOG.
2. SPBK1 NORD-NORGE (NONG.OL)
16.3% sales growth and 16.76% return on equity
SpareBank 1 Nord-Norge provides banking services in Northern Norway. It operates through Retail Market and Corporate Market segments. The company offers mortgage, car, boat, vehicle, and other loan related services. It also offers vehicle, home, travel, personal, and pet insurance services. In addition, the company provides various savings and pension related services, as well as debit and credit card services. Further, it offers accounting services, real estate brokerage, and leasing/sale-leaseback financing, internet banking, and mobile services. SpareBank 1 Nord-Norge was founded in 1836 and is headquartered in Tromsø, Norway.
Earnings Per Share
As for profitability, SPBK1 NORD-NORGE has a trailing twelve months EPS of kr12.37.
PE Ratio
SPBK1 NORD-NORGE has a trailing twelve months price to earnings ratio of 8.7. Meaning, the purchaser of the share is investing kr8.7 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.76%.
Sales Growth
SPBK1 NORD-NORGE’s sales growth is 20% for the ongoing quarter and 16.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 50.2% and 33.9%, respectively.
Moving Average
SPBK1 NORD-NORGE’s worth is above its 50-day moving average of kr103.35 and above its 200-day moving average of kr100.54.
More news about SPBK1 NORD-NORGE.
3. AZERION (AZRN.AS)
10.7% sales growth and 23.87% return on equity
Azerion Group N.V. operates a digital entertainment and media platform in the Netherlands, Germany, France, Great Britain, Ireland, Italy, other Nordic and European countries, the United States, the United Arab Emirates, and internationally. The company operates in two segments, Platform and Premium Games. Its integrated platform offers technology solutions to automate the purchase and sale of digital advertising inventory for advertisers, publishers, and game creators, as well as to develop, publish, distribute, and operate online social and casual games, and digital content. The company also operates Hawk, a digital advertising technology platform. Azerion Group N.V. was founded in 2013 and is headquartered in Schiphol-Rijk, the Netherlands.
Earnings Per Share
As for profitability, AZERION has a trailing twelve months EPS of €0.17.
PE Ratio
AZERION has a trailing twelve months price to earnings ratio of 9.19. Meaning, the purchaser of the share is investing €9.19 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 522M for the twelve trailing months.
Yearly Top and Bottom Value
AZERION’s stock is valued at €1.56 at 07:20 EST, way under its 52-week high of €2.80 and way higher than its 52-week low of €1.27.
Volume
Today’s last reported volume for AZERION is 175745 which is 363.71% above its average volume of 37899.
More news about AZERION.
4. KID (KID.OL)
7.5% sales growth and 29.84% return on equity
Kid ASA, together with its subsidiaries, operates as a home textile retailer in Norway, Sweden, Finland, and Estonia. It designs, sources, markets, and sells a range of home and interior products, including textiles, curtains, bed linens, home accessories, decorations, furniture, and other interior products through retail stores and online platforms. The company provides its products under the Kid, Hemtex, Dekosol, Nordun, and Premium Collection brands. It also offers logistics services. The company was formerly known as Nordisk Tekstil Holding AS and changed its name to Kid ASA. Kid ASA was founded in 1937 and is headquartered in Lier, Norway.
Earnings Per Share
As for profitability, KID has a trailing twelve months EPS of kr8.94.
PE Ratio
KID has a trailing twelve months price to earnings ratio of 16.78. Meaning, the purchaser of the share is investing kr16.78 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.84%.
More news about KID.
5. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 19.84% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.54.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 15.13. Meaning, the purchaser of the share is investing kr15.13 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the present quarter and 6.6% for the next.
Volume
Today’s last reported volume for VISTIN PHARMA is 184 which is 99.11% below its average volume of 20743.
More news about VISTIN PHARMA.
6. IMCD (IMCD.AS)
5.4% sales growth and 16.47% return on equity
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives. It offers actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, film formers, humectants, waxes, conditioners, hair styling polymers, solvent, solubilizers, pigments, pearls, powders and colorants, opacifiers, pearlizers, preservatives, antioxidants, fragrances, and essential oils. In addition, the company provides functional fillers, pigments, resins, and specialty solvents; taste, texture, nutrition, and function; and abrasives, acids, alkalines, anti-soil redeposition and foam control systems, bio-actives, biocides, bittering and bleaching agents, builders, capsules, chelating agents, concentrates/ready-to-use, corrosion and dye transfer inhibitors, disintegrants, dispersants, emulsifiers, enzymes, fluorinated polymers, oleo chemicals, optical brighteners, perfumes, dyes, phosphates, plasticisers, proteins, rheology modifiers and thickeners, silicones, solvents/diluents, TAED, UV-filters, and waxes. Further, it offers base oils; lubricants addictive; lubricants finished fluids; fuel additives; solvents, degreasers, and fuel compounds; and upstream, midstream, and downstream oil, gas, and energy. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €4.92.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 29.77. Meaning, the purchaser of the share is investing €29.77 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.47%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.2%, now sitting on 4.56B for the twelve trailing months.
Volume
Today’s last reported volume for IMCD is 11937 which is 86.64% below its average volume of 89413.
Moving Average
IMCD’s value is above its 50-day moving average of €134.12 and higher than its 200-day moving average of €144.26.
More news about IMCD.
